“Smart Health” to Feature Brown Alpert Medical School Cancer Specialist El-Deiry LIVE on Weds

“Smart Health” to Feature Brown Alpert Medical School Cancer Specialist El-Deiry LIVE on Weds

“Smart Health,” the new GoLocalProv.com segment featuring experts from The Warren Alpert Medical School at Brown University on GoLocal LIVE, will feature Wafik El-Deiry, MD, PhD, FACP, an internationally recognized physician-scientist, academic leader, and medical oncologist who Brown recruited to come to the school last fall, on Wednesday, May 29 at 5:30 P.M on LIVE.

“Developing a transdisciplinary, translational cancer biology program with innovative science, and collaboration across institutions can be transformative for our institutions. As a former Howard Hughes Investigator and American Cancer Society Research Professor, Dr. El-Deiry is a person of immense stature in oncology and oncologic sciences,” said Jack A. Elias, MD, senior vice president for health affairs and dean of medicine and biological sciences at Brown. “I look forward to watching our programs grow and our oncologic services to the people of Rhode Island expand under his leadership.”

Since granting its first Doctor of Medicine degrees in 1975, the Warren Alpert Medical School has become a national leader in medical education and biomedical research. By attracting first-class physicians and researchers to Rhode Island over the past four decades, the Medical School and its seven affiliated teaching hospitals have radically improved the state's health care environment, from health care policy to patient care.

About El-Deiry

El-Deiry, whose expertise lies in gastrointestinal cancers, served as deputy director for translational research and co-leader of the Molecular Therapeutics Program at Fox Chase Cancer Center. 

Prior to that, he served as the chief of hematology/oncology and associate director of the Cancer Institute at Penn State University, and as a tenured professor of medicine, genetics, and pharmacology at the University of Pennsylvania Perelman School of Medicine, and co-program leader at the Abramson Comprehensive Cancer Center.

Earlier this month, Brown University joined the Caris Life Sciences’ Precision Oncology Alliance.

"The Precision Oncology Alliance is providing evidence that precision therapeutics – targeted therapies based on molecular characteristics of tumors – can prolong the survival of patients," said El-Deiry.  "Brown University is excited to join the Precision Oncology Alliance and to contribute to the growing body of data that is helping establish how patients with cancer are treated." 

El-Deiry, who serves as the co-chair of the Steering Committee and the leader of the Phase 1 Disease Group for the Precision Oncology Alliance, also noted, "The Alliance will give Brown-affiliated faculty the opportunity to be involved with the national committees designing and leading innovative precision oncology trials."